Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 7,452,000 | 4,279,000 | 3,686,000 | 3,301,000 | 4,276,000 |
| Income taxes - deferred | -1,753,000 | -727,000 | -909,000 | -542,000 | -1,253,000 |
| Accounts receivable | -462,000 | -35,000 | -529,000 | 168,000 | -493,000 |
| Accounts payable and accrued liabilities | 169,000 | 270,000 | 577,000 | 447,000 | 241,000 |
| Other Working Capital | -419,000 | -1,280,000 | 148,000 | 828,000 | 1,055,000 |
| Other Operating Activity | 2,757,000 | 3,040,000 | 4,406,000 | 3,636,000 | 5,094,000 |
| Operating Cash Flow | $7,744,000 | $5,547,000 | $7,379,000 | $7,838,000 | $8,920,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -592,000 | 186,000 | -1,421,000 | -1,874,000 | -2,561,000 |
| Net Acquisitions | -488,000 | -12,857,000 | -1,151,000 | -426,000 | -220,000 |
| Purchase Of Investment | -38,000 | -137,000 | -161,000 | -208,000 | -142,000 |
| Other Investing Activity | 60,000 | -64,000 | 3,372,000 | -3,000 | -334,000 |
| Investing Cash Flow | $-1,058,000 | $-12,872,000 | $639,000 | $-2,511,000 | $-3,257,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -154,000 | -168,000 | 30,000 | 96,000 | -199,000 |
| Debt Issued | 1,997,000 | 9,677,000 | 41,000 | 4,773,000 | 2,253,000 |
| Debt Repayment | -2,334,000 | -787,000 | -2,368,000 | -2,576,000 | -708,000 |
| Common Stock Issued | 162,000 | 177,000 | 319,000 | 305,000 | 574,000 |
| Common Stock Repurchased | -9,000 | -1,101,000 | -2,162,000 | -2,908,000 | -1,784,000 |
| Dividend Paid | -3,834,000 | -3,773,000 | -3,710,000 | -3,759,000 | -3,694,000 |
| Other Financing Activity | -21,000 | -91,000 | -52,000 | -32,000 | -43,000 |
| Financing Cash Flow | $-4,193,000 | $3,934,000 | $-7,902,000 | $-4,101,000 | $-3,601,000 |
| Exchange Rate Effect | 9,000 | 1,000 | -74,000 | -101,000 | -232,000 |
| Beginning Cash Position | 6,925,000 | 10,315,000 | 10,273,000 | 9,148,000 | 7,341,000 |
| End Cash Position | 9,427,000 | 6,925,000 | 10,315,000 | 10,273,000 | 9,148,000 |
| Net Cash Flow | $2,493,000 | $-3,391,000 | $116,000 | $1,226,000 | $2,039,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,744,000 | 5,547,000 | 7,379,000 | 7,838,000 | 8,920,000 |
| Capital Expenditure | -1,816,000 | -1,977,000 | -1,956,000 | -2,083,000 | -2,772,000 |
| Free Cash Flow | 5,928,000 | 3,570,000 | 5,423,000 | 5,755,000 | 6,148,000 |